Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 33,349 | 27,530 | 23,798 | 26,081 | 25,919 |
| Operating Income | -33,349 | -27,530 | -23,798 | -26,081 | -25,919 |
| Interest Expense | 0 | 1 | 1 | 1 | 2 |
| Other Income | 2,415 | 2,796 | 2,846 | 4,066 | 3,274 |
| Pre-tax Income | -30,934 | -24,735 | -20,953 | -22,016 | -22,647 |
| Net Income Continuous | -30,934 | -24,735 | -20,953 | -22,016 | -22,647 |
| Net Income | $-30,934 | $-24,735 | $-20,953 | $-22,016 | $-22,647 |
| EPS Basic Total Ops | -1.39 | -1.12 | -0.99 | -1.05 | -1.08 |
| EPS Basic Continuous Ops | -1.39 | -1.12 | -0.99 | -1.05 | -1.08 |
| EPS Diluted Total Ops | -1.39 | -1.12 | -0.99 | -1.05 | -1.08 |
| EPS Diluted Continuous Ops | -1.39 | -1.12 | -0.99 | -1.05 | -1.08 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.12 | -0.99 | -1.05 | -1.08 |
| EBITDA(a) | $-32,869 | $-27,243 | $-23,838 | $-26,787 | $-26,904 |